Dimethyl fumarate treatment in relapsed and refractory cutaneous T cell lymphoma - a multicenter phase II study. Nicolay JP, Melchers S, Albrecht JD, Assaf C, et al. Blood 2023 May 22:blood.2022018669. doi: 10.1182/blood.2022018669.

Read + Share

Amedeo Smart

Independent Medical Education

Nicolay JP, Melchers S, Albrecht JD, Assaf C, et al. Dimethyl fumarate treatment in relapsed and refractory cutaneous T cell lymphoma - a multicenter phase II study. Blood 2023 May 22:blood.2022018669. doi: 10.1182/blood.2022018669.
PMID: 37217183